Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Oxford University Clinical Research Unit-Nepal (OUCRU-NP) is hosted by Patan Hospital and the Patan Academy of Health Sciences in Kathmandu Nepal and works in close collaboration with the Nepal Health Research Council at the Nepalese Ministry of Health and Population. Our mission is to build a strong critical mass of young Nepalese clinician scientists who can help build Nepal's scientific and clinical future.

Oucru nepal 2018

OUCRU-NP was initiated in the summer of 2003 following a visit to Nepal by Professor Jeremy Farrar after an exchange of letters with Dr Buddha Basnyat (Consultant, Patan Hospital) in the New England Journal of Medicine, subsequent to a review article by Professor Farrar and colleagues on typhoid fever.

Since 2003, the research collaboration has evolved and OUCRU-NP has become a respected and integral part of the work of both the Patan Hospital and the Patan Academy of Health Sciences. There has been considerable investment in upgrading the hospital laboratories including Microbiology and now Biochemistry, Heamatology and Pathology, in the Clinical Research Unit and in the training of young Nepalese clinicians and scientists. Our main research focus has been on the most common infectious diseases affecting patients at Patan Hospital and in the surrounding areas of Lalipitur.  We have a major focus on enteric fever (Typhoid and Paratyphoid) and other causes of febrile illness including typhus, infections of the central nervous system and Hepatitis E.  We plan in the future to expand this work to include viral causes of pneumonia, TB, emerging illnesses and other public health priorities in Nepal. High altitude sickness in Nepalese and travellers has also been an interest of this collaboration over the last ten years.

Every year thousands of pilgrims visit religious sites in the mountains of Nepal. Many of these local pilgrims are unaware of the dangers of climbing to high altitudes and many succumb to altitude related illnesses. Some even die on the mountains. The Himalayan Rescue Association, OUCRU Public Engagement and Media for Development worked together with the pilgrim community to create a public health film to inform others of the challenges of these journeys.

Our team

Latest news

World malaria day 2019

Faces of malaria

Today April 25 is World Malaria Day. We would like to highlight a malaria photography project by photographer Pearl Gan, in collaboration with OUCRU in Vietnam and EOCRU in Indonesia. Pearl's malaria project aims to bring visibility to the people and their malaria burden through her photographs of them and their environment. She hopes to humanise the faces of malaria and the malaria problem in the Asia-Pacific to audiences unfamiliar with it.

Oucru photographer in residence recognised by isntd

OUCRU Photographer in Residence recognised by ISNTD

OUCRU Photographer in Residence Pearl Gan has been awarded the International Society for Neglected Tropical Diseases (ISNTD) Festival Award for her submission to the ISNTD Festival Showcase. Pearl submission included seven photographs, and was recognised for its impact on tropical diseases and its broader development goals.

Congratulations to jeremy farrar knighted in the new years honours 2019

Congratulations to Jeremy Farrar, knighted in the New Year's Honours 2019.

Director of Wellcome since 2013, Jeremy Farrar was previously Director of our OUCRU Vietnam programme for 18 years. He has published almost 600 peer-reviewed scientific papers, and mentored many dozens of students and fellows. These honours recognise the outstanding commitment and contribution Jeremy has made to science and medicine, and to improving health for individuals and communities globally.

OUCRU Nepal Research Highlights

  • Melioidosis: misdiagnosed in Nepal

    Posted 02/04/2019: Underdiagnosed in South Asia, melioidosis is caused by a bacterium called Burkholderia pseudomallei which is often referred to as a remarkable imitator. Pulmonary involvement including infections mimicking tuberculosis is a common form of presentation. In this case report, Buddha Basnyat and colleagues show that if a South Asian patient does not respond to anti tuberculosis treatment, melioidosis should be considered.

  • Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions

    Posted 19/06/2018. Many people with pre-existing heart problems (including heart attack, pacemaker implantation, arrhythmia), high blood pressure and even past history of a stroke seek advice regarding high altitude travel ( > 2500m) for recreation, meetings or pilgrimages. Dr Buddha Basnyat and colleagues succinctly try to address these conditions at altitude and make reasonable recommendations in the face of limited data.

  • Prophylactic acetaminophen or ibuprofen result in equivalent acute mountain sickness incidence at high altitude

    Posted 30/06/2017. Acute mountain sickness is a potentially life-threatening illness for sojourners to high altitude (> 2500m). Where pharmacological prophylaxis is indicated, Diamox is the drug of choice, but it has distressing side-effects. This Everest-based, double-blind, randomized controlled trial revealed that paracetamol, like ibuprofen, could potentially replace Diamox for prophylaxis.

  • Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance

    Posted 25/04/2017. South Asia, which includes Nepal, is a hub for typhoid fever. Trials conducted in Nepal since 2005 confirm that fluoroquinolones are failing for typhoid fever treatment. The WHO and health ministries in the region recommend fluroquionolones as the drugs of choice for typhoid fever. This recommendation needs to be changed.